The longitudinal effect of oxcarbazepine on thyroid function in children and adolescents with epilepsy.
Hyunju ParkJung HeoMin-Ji KimJee-Hun LeeMin-Sun KimDong-Kyu JinTae Hyuk KimJae Hoon ChungSung Yoon ChoSun Wook KimPublished in: Epilepsia (2022)
Serum T3, T4, and fT4 levels decreased significantly during oxcarbazepine use, and this change was maintained during the treatment period. In patients receiving oxcarbazepine, it is recommended that periodic thyroid function testing should be performed, especially within the first 2 years after starting this ASM. Our results indicate that oxcarbazepine-induced hypothyroidism does not appear to be accompanied by a significant increase in TSH, and consequently might be missed if TSH alone is monitored as a measure of thyroid dysfunction.